Source: Contract Pharma

Prosolus Pharmaceuticals: ProSolus Expands Transdermal Drug Delivery Capabilities

Parent company Mission Pharmacal invests in patch technology, doubles manufacturing footprint

Read full article »
Prosolus Pharmaceuticals's Competitors | Prosolus Pharmaceuticals's News | Prosolus Pharmaceuticals's Financials
Stay up-to-date with the latest news on ProSolus
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Alex Moreno's photo - CEO of ProSolus

CEO

Alex Moreno

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on ProSolus